REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 172 filers reported holding REGENXBIO INC in Q2 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $175,219,000 | +6.5% | 4,180 | -7.2% | 0.04% | +13.5% |
| Q2 2021 | $164,510,000 | +16.0% | 4,506 | +8.4% | 0.04% | -9.8% |
| Q1 2021 | $141,823,000 | -21.0% | 4,158 | +5.1% | 0.04% | -22.6% |
| Q4 2020 | $179,527,000 | +107.4% | 3,958 | +25.9% | 0.05% | +112.0% |
| Q3 2020 | $86,546,000 | -13.4% | 3,145 | +15.9% | 0.02% | -7.4% |
| Q2 2020 | $99,950,000 | +21964.0% | 2,714 | +19285.7% | 0.03% | – |
| Q1 2020 | $453,000 | -32.0% | 14 | 0.0% | 0.00% | – |
| Q4 2019 | $666,000 | +33.7% | 14 | 0.0% | 0.00% | – |
| Q3 2019 | $498,000 | -30.7% | 14 | 0.0% | 0.00% | – |
| Q2 2019 | $719,000 | -10.3% | 14 | 0.0% | 0.00% | – |
| Q1 2019 | $802,000 | -92.8% | 14 | -94.7% | 0.00% | -100.0% |
| Q4 2018 | $11,155,000 | -46.1% | 266 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $20,687,000 | -92.7% | 266 | -93.4% | 0.00% | -91.5% |
| Q2 2018 | $284,280,000 | +149.0% | 4,000 | 0.0% | 0.05% | +104.3% |
| Q1 2018 | $114,156,000 | – | 4,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 1,459,128 | $110,164,000 | 6.60% |
| ArchPoint Investors | 224,187 | $16,926,000 | 4.60% |
| Redmile Group, LLC | 1,656,065 | $125,033,000 | 3.85% |
| WS MANAGEMENT LLLP | 954,812 | $72,088,000 | 2.37% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 342,000 | $25,821,000 | 1.19% |
| Perceptive Advisors | 470,672 | $35,536,000 | 0.95% |
| Pier Capital, LLC | 94,492 | $7,134,000 | 0.90% |
| Ipswich Investment Management Co., Inc. | 29,932 | $2,260,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 275,000 | $20,763,000 | 0.74% |
| Timpani Capital Management LLC | 27,835 | $2,102,000 | 0.61% |